Novartis India
Signals mentioning Novartis India
- ChrysCapital earmarks up to $550m of $2.2bn fund for Indian pharma and healthcare
- Novartis India buys Pfizer’s Minipress brands for ₹1,250 crore
- Novartis India to acquire Pfizer’s Minipress trademarks and India IP for ₹1,250 crore
- Novartis India targets Tier 2 and 3 reach, therapy-aligned acquisitions
- Novartis India targets therapy-led acquisitions and deeper Tier 2-3 reach
- Novartis India targets Tier 2 and 3 expansion, therapy-aligned acquisitions
- Dr Reddy’s ends Novartis India distribution pact after ownership change